REFERENCES
- Dickinson R. G., Hooper W. D., Dunstan P. R., Eadie M. J. Urinary Excretion of Valproate and Some Metabolites in Chronically Treated Patients. Ther. Drug Monit. 1989; 11: 127–33
- Stata C. STATA for Windows Stata Corporation. College Station, TX 77840 1995
- Hooper W., Franklin M., Glue P., Banfield C., Radwanski E., McLaughlin D., McIntyre M., Dickinson R., Eadie M. Effect of Felbamate on Valproic Acid Disposition in Healthy Volunteers: Inhibition of b-Oxidation. Epilepsia 1996; 37: 91–97
- Bartels H., Bohmer M., Heierli C. Serum Creatinine Determination without Protein Precipitation. Clin. Chim. Acta 1972; 37: 193–97
- Rowland M., Tozer T. N. Clinical Pharmacokinetics: Concepts and Applications. Williams and Wilkins, Median 1995
- Granneman G., Marriott T., Wang S., Sennello L., Hagen N., Sonders R. Aspects of the Dose-Dependent Metabolism of Valproic Acid. Metabolism of Antiepileptic Drugs, R. Levy. Raven Press, , New York 1984; 97–104
- Yoshiyama Y., Nakano S., Ogawa N. Chronopharmacokinetic Study of Valproic Acid in Man: Comparison of Oral and Rectal Administration. J. Clin. Pharmacol. 1989; 29: 1048–52
- Levy R. H., Lockard J. S., Patel I. H., Congdon W. C. Time-Dependent Kinetics III: Diurnal Oscillations in Steady-State Plasma Valproic Acid Levels in Rhesus Monkeys. J. Pharm. Sci. 1977; 66: 1154–56
- Lockard J. S., Levy R. H., DuCharme L. L., Congdon W. C., Patel I. H. Diurnal Variation of Valproic Acid Plasma Levels and Day–Night Reversal in Monkey. Epilepsia 1977; 18: 183–89
- Ohdo S., Nakano S., Ogawa N. Chronopharmacokinetics of Valproic Acid Following Constant-Rate Administration in Mice. Chonobiol. Int. 1991; 8: 35–43
- Royer-Morrot M., Zhiri A., Jacob F., Necciari J., Lascombes F., Royer R. Influence of Food Intake on the Pharmacokinetics of a Sustained Release Formulation of Sodium Valproate. Biopharm. Drug Dispos. 1993; 14: 511–18
- Ohdo S., Ogawa N., Nakano S., Higuchi S. Influence of Feeding Schedule on the Chronopharmacological Aspects of Sodium Valproate in Mice. J. Pharmacol. Exp. Ther. 1996; 278: 74–81
- Ohdo S., Watanabe H., Ogawa N., Yoshiyama Y., Sugiyama T. Circadian Rhythm of Embryotoxicity Induced by Sodium Valproate in Mice. Eur. J. Pharmacol. 1995; 293: 281–85
- Ohdo S., Nakano S., Ogawa N. Chronotoxicity of Sodium Valproate and Its Mechanisms in Mice. Chronobiol. Int. 1989; 6: 229–325
- Bauer L., Davis R., Wilensky A., Raisys V., Levy R. Valproic Acid Clearance: Unbound Fraction and Diurnal Variation in Young and Elderly Adults. Clin. Pharmacol. Ther. 1985; 37: 697–700
- Zorab P. Normal Creatinine and Hydroxyproline Excretion in Young Persons. Lancet 1969; 2: 1164, 1165
- Webster J., Garrow J. Creatinine Excretion over 24 Hours as a Measure of Body Composition or of Completeness of Urine Collection. Hum. Nutr. Clini. Nutr. 1985; 39C: 101–6
- Edwards O., Bayliss R., Millen S. Urinary Creatinine Excretion as an Index of the Completeness of 24-hour Urine Collections. Lancet 1969; 2: 1165–66
- Koren G., Ferrazzini G., Sohl H., Robieux I., Johnson D., Giesbrecht E. Chronopharmacology of Methotrexate Pharmacokinetics in Childhood Leukaemia. Chronobio. Int. 1992; 9: 434–38